PEMM/COPPE, Federal University of Rio de Janeiro, Department of Materials Science and Engineering, P.O. Box 68505, 21945-970 Rio de Janeiro, RJ, Brazil.
PEMM/COPPE, Federal University of Rio de Janeiro, Department of Materials Science and Engineering, P.O. Box 68505, 21945-970 Rio de Janeiro, RJ, Brazil; PENT/COPPE, Federal University of Rio de Janeiro, P.O. Box 68505, 21945-970 Rio de Janeiro, RJ, Brazil; National Institute of Metrology Quality and Technology (Inmetro), Materials Metrology Division (DIMAT), Av. Nossa Sra. das Graças, 50 - Xerém, 25250-020 Duque de Caxias, RJ, Brazil.
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110852. doi: 10.1016/j.msec.2020.110852. Epub 2020 Mar 14.
The present study describes the development of a chlorhexidine long-term drug delivery system using starch as a biodegradable polymer base. Three batches of thermoplastic starch films, containing starch particles/nanoparticles and chlorhexidine (CHX), were manufactured by casting. Morphological characterization showed an irregular surface with particles incorporated with chlorhexidine agglomerated in a starch matrix. Nanoindentation showed that the control film (without chlorhexidine) presented a more plastic and rigid behavior in relation to the films containing CHX. CHX was partially bounded to starch and prevented starch crystallization. Starch nanoparticles formed by precipitation were observed through transmission electron microscopy. By incorporating CHX into the solution, the nanoparticles presented different morphology, suggesting absorption of the drug. In vitro drug release was observed for 21 days by UV-vis spectrophotometry and released CHX amounted up to 19 mg/100 ml. Films presented microbiological potential for inhibiting Staphylococcus aureus growth as evaluated by the disk diffusion test in agar. It has been concluded that the developed film met the main requirements for a drug delivery system and that it is possible to be produced from a simple, cheap and reproduceable process.
本研究描述了一种使用淀粉作为可生物降解聚合物基质的氯己定长效药物输送系统的开发。通过浇铸制造了三批包含淀粉颗粒/纳米颗粒和氯己定(CHX)的热塑性淀粉薄膜。形态特征表明,表面不规则,含有氯己定的颗粒在淀粉基质中聚集。纳米压痕表明,不含氯己定的对照薄膜(control film)与含有 CHX 的薄膜相比表现出更具塑性和刚性的行为。通过透射电子显微镜观察到通过沉淀形成的淀粉纳米颗粒。通过将 CHX 掺入溶液中,纳米颗粒呈现出不同的形态,表明药物被吸收。通过紫外可见分光光度法观察到 21 天的体外药物释放,释放的 CHX 高达 19mg/100ml。通过琼脂中的圆盘扩散试验评估,薄膜具有抑制金黄色葡萄球菌生长的微生物潜力。研究得出结论,所开发的薄膜满足药物输送系统的主要要求,并且可以通过简单、廉价和可重复的工艺进行生产。